Study: Heart failure drug guidelines often ignored

Oct 20, 2009 By LINDSEY TANNER , AP Medical Writer

(AP) -- Most hospitalized heart failure patients are sent home without widely recommended inexpensive pills, despite a program to get more doctors to follow treatment guidelines, a study suggests.

Only one-third of 12,565 patients eligible for the drugs got them - even though they were treated at 201 hospitals that had voluntarily enrolled in the American Heart Association's Get with the Guidelines program.

Reasons why so few doctors "got with the program" are unclear. But the study authors offered some theories, from lack of marketing for the decades-old drugs to concerns about their safety.

The main drug studied, spironolactone, is a water pill that helps prevent kidneys from absorbing too much sodium, which can lead to excess fluid. In heart failure, water often builds up in lungs, blood and tissue because the heart can't pump properly.

The pills studied have been shown to reduce hospitalizations and deaths. But they also can be hard on the kidneys and when used in the wrong patients, side effects can be deadly - another reason some doctors may avoid them.

The study found that inappropriate use - in patients with signs of kidney trouble or other specific conditions - was uncommon.

The study appears in Wednesday's .

Spironolactone is an old that is not heavily marketed, so doctors may lack promotional material on how to use it, said Cleveland Clinic researcher Nancy Albert, the study's lead author.

Another reason for infrequent use is that the original 2005 American College of Cardiology/American Heart Association guidelines said these drugs "should be considered." The wording was changed this year to "recommended," after the 2005-2007 study ended, the study authors said.

Dr. Ileana Pina, a spokeswoman for the heart group and professor at Cleveland's Case Western Reserve University, said the results aren't surprising since other reports have shown doctors don't always follow guidelines.

But because these drugs can improve survival, she said the study results should serve as "a call to action" for doctors who treat patients.

On the Net:

JAMA: http://jama.ama-assn.org

American Heart Association: http://www.heart.org

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: The impact of bacteria in our guts

add to favorites email to friend print save as pdf

Related Stories

Recommended treatment for heart failure often underused

Oct 20, 2009

Less than one-third of patients hospitalized for heart failure and participating in a quality improvement registry received a guideline-recommended treatment of heart failure, aldosterone antagonist therapy, according to ...

Statin cuts heart problems after artery surgery

Sep 02, 2009

(AP) -- Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive ...

Recommended for you

The impact of bacteria in our guts

16 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

16 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

17 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 0